翻动 发表于 2025-3-26 21:57:25

http://reply.papertrans.cn/47/4647/464687/464687_31.png

圆锥 发表于 2025-3-27 03:57:38

http://reply.papertrans.cn/47/4647/464687/464687_32.png

食品室 发表于 2025-3-27 05:45:21

The Case for Complement and Inflammation in AMD: Open Questions,

Petechiae 发表于 2025-3-27 12:37:47

Multiple Interactions of Complement Factor H with Its Ligands in Solution: A Progress Report,

AMITY 发表于 2025-3-27 16:01:11

Genetic Control of Complement Activation in Humans and Age Related Macular Degeneration,

闪光东本 发表于 2025-3-27 21:17:40

Bisretinoids of RPE Lipofuscin: Trigger for Complement Activation in Age-Related Macular Degenerati

cuticle 发表于 2025-3-27 22:30:01

http://reply.papertrans.cn/47/4647/464687/464687_37.png

入伍仪式 发表于 2025-3-28 03:05:34

http://reply.papertrans.cn/47/4647/464687/464687_38.png

disparage 发表于 2025-3-28 07:37:11

Suppression of Drusen Formation by Compstatin, a Peptide Inhibitor of Complement C3 activation, on

会犯错误 发表于 2025-3-28 11:05:56

A Targeted Inhibitor of the Complement Alternative Pathway Reduces RPE Injury and Angiogenesis in M
页: 1 2 3 [4] 5
查看完整版本: Titlebook: Inflammation and Retinal Disease: Complement Biology and Pathology; John D. Lambris,Anthony P. Adamis Conference proceedings 2010 The Edit